Properties and Mechanisms of Deletions, Insertions, and Substitutions in the Evolutionary History of SARS-CoV-2.

ADAR APOBEC SARS-CoV-2 epistasis low-complexity regions mutation hotspots oxidative stress viral fitness

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Mar 2024
Historique:
received: 25 02 2024
revised: 22 03 2024
accepted: 23 03 2024
medline: 13 4 2024
pubmed: 13 4 2024
entrez: 13 4 2024
Statut: epublish

Résumé

SARS-CoV-2 has accumulated many mutations since its emergence in late 2019. Nucleotide substitutions leading to amino acid replacements constitute the primary material for natural selection. Insertions, deletions, and substitutions appear to be critical for coronavirus's macro- and microevolution. Understanding the molecular mechanisms of mutations in the mutational hotspots (positions, loci with recurrent mutations, and nucleotide context) is important for disentangling roles of mutagenesis and selection. In the SARS-CoV-2 genome, deletions and insertions are frequently associated with repetitive sequences, whereas C>U substitutions are often surrounded by nucleotides resembling the APOBEC mutable motifs. We describe various approaches to mutation spectra analyses, including the context features of RNAs that are likely to be involved in the generation of recurrent mutations. We also discuss the interplay between mutations and natural selection as a complex evolutionary trend. The substantial variability and complexity of pipelines for the reconstruction of mutations and the huge number of genomic sequences are major problems for the analyses of mutations in the SARS-CoV-2 genome. As a solution, we advocate for the development of a centralized database of predicted mutations, which needs to be updated on a regular basis.

Identifiants

pubmed: 38612505
pii: ijms25073696
doi: 10.3390/ijms25073696
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : 2 U54 MD007600-31
Pays : United States
Organisme : NIGMS NIH HHS
ID : R25 GM061838
Pays : United States

Auteurs

Igor B Rogozin (IB)

Life Science Research Centre, Faculty of Science, University of Ostrava, 710 00 Ostrava, Czech Republic.

Andreu Saura (A)

Life Science Research Centre, Faculty of Science, University of Ostrava, 710 00 Ostrava, Czech Republic.

Eugenia Poliakov (E)

National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Anastassia Bykova (A)

Life Science Research Centre, Faculty of Science, University of Ostrava, 710 00 Ostrava, Czech Republic.

Abiel Roche-Lima (A)

Center for Collaborative Research in Health Disparities-RCMI Program, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.

Youri I Pavlov (YI)

Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Vyacheslav Yurchenko (V)

Life Science Research Centre, Faculty of Science, University of Ostrava, 710 00 Ostrava, Czech Republic.

Classifications MeSH